7/16/2024  9:59:57 PM Chg. +0.47 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
437.83USD +0.11% 50,284
Turnover: 21.97 mill.
-Bid Size: - -Ask Size: - 155.36 bill.USD - 85.55

Business description

Intuitive Surgical, Inc., headquartered in Sunnyvale, California, is the global technology leader in robotic-assisted, minimally invasive surgery. Intuitive Surgical develops, manufactures and markets robotic technologies designed to improve clinical outcomes and help patients return more quickly to active and productive lives. The Company's mission is to extend the benefits of minimally invasive surgery to the broadest possible base of patients.
 

Management board & Supervisory board

CEO
Dr. Gary S. Guthart
Management board
Jamie Samath, Dave Rosa, Myriam J. Curet, Brian Miller, Bob DeSantis, Gary Loeb, Kara Andersen Reiter, Marshall L. Mohr, Henry Charlton, Marc Bland, Dirk Barten, Glenn Vavoso, Lesly Marban, Julian Nikolchev, Gillian S. Duncan, Chris Carlson, Iman Jeddi, Charlie Dean, Ian Purdy, Mark Brosius
Supervisory board
Craig H. Barratt, Dr. Gary S. Guthart, Joseph C. Beery, Amal M. Johnson, Amy L. Ladd, Keith R. Leonard, Jami Dover Nachtsheim, Monica P. Reed, Mark J. Rubash, Lewis Chew
 

Company data

Name: Intuitive Surgical Inc.
Address: 1020 Kifer Road, Building 101,Sunnyvale, California 94086-5304, USA
Phone: +1-408-523-2100
Fax: +1-408-523-1390
E-mail: -
Internet: www.intuitivesurgical.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 60.88%
IPO date: 6/13/2000

Investor relations

Name: -
IR phone: +1-408-523-2161
IR Fax: -
IR e-mail: investor.relations@i...urg.com investor.relations@intusurg.com

Company calendar

CW 29 | 7/18/2024 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Others
 
24.29%
Vanguard Group Inc
 
8.70%
Vanguard Group
 
8.56%
Blackrock Inc.
 
8.55%
BlackRock Inc.
 
8.24%
PRICE T ROWE ASSOCIATES INC MD
 
4.79%
Price (T.Rowe) Associates Inc
 
4.66%
State Street Corporation
 
4.27%
State Street Corporation
 
4.22%
Others
 
23.72%